8-K12B/A: ProKidney Completes Corporate Domestication to Delaware, Restructures Subsidiaries

ProKidney Corp. has completed its corporate domestication from the Cayman Islands to Delaware and restructured its subsidiary entities, streamlining its corporate governance and operational framework.

Summary

• ProKidney Corp. completed its domestication from the Cayman Islands to Delaware, effective July 1, 2025, changing its jurisdiction of incorporation.
• The restructuring involved ProKidney Cayman deregistering in the Cayman Islands and continuing its existence as a Delaware corporation.
• ProKidney LP, an Irish limited partnership, contributed substantially all assets to a newly formed Delaware limited liability company, ProKidney Holdings, LLC, and subsequently commenced winding-up.
• ProKidney-KY, a former wholly-owned subsidiary, domesticated to a Delaware LLC named ProKidney IPCo, LLC.
• As a result of the restructuring, ProKidney Corp. and other former limited partners of PKLP are now members of ProKidney Holdings, which owns all business subsidiaries, including ProKidney IPCo.
• Key material agreements, including the Tax Receivable Agreement, Lock-Up Agreement, and Exchange Agreement, were amended and restated to reflect the new corporate structure.
• A Second Amended and Restated Limited Liability Company Agreement of ProKidney Holdings was adopted to govern ProKidney Holdings, outlining unit rights, management by a Holdings Board, and distribution policies.
• Each Class A and Class B ordinary share of ProKidney Cayman was automatically converted into one share of Class A and Class B common stock of ProKidney Delaware, respectively, with the same number of shares outstanding.
• Various Class B Restricted Stock Rights (RSRs) were converted to corresponding Delaware RSRs for Class B common stock, retaining original vesting conditions.
• The Class A common stock continues to be listed on the Nasdaq Capital Market under the symbol PROK, and the CUSIP number changed to 74291D 104.
• The company adopted an Amendment to the 2022 Incentive Equity Plan and an Amendment to the Employee Stock Purchase Plan to reflect the domestication.
• ProKidney Delaware is now the successor registrant to ProKidney Cayman under the Securities Exchange Act of 1934.

Sentiment

Score: 5

Explanation: The filing is administrative in nature, reporting on a completed corporate domestication and restructuring. It does not contain information that would significantly alter the company's operational or financial prospects, thus maintaining a neutral sentiment.

Positives

• Streamlined corporate structure by domesticating to Delaware, potentially simplifying regulatory compliance and investor relations for U.S. investors.
• Amended agreements ensure continuity of existing terms and obligations under the new corporate structure.
• Indemnification agreements provide protection for directors and officers, which can aid in attracting and retaining talent.

Negatives

• The Tax Receivable Agreement may result in ProKidney Delaware paying 85% of certain tax savings to holders of ProKidney Holdings common units, potentially reducing cash available to the company.
• ProKidney Delaware may receive tax distributions significantly in excess of its tax liabilities and obligations under the tax receivable agreement, which could be seen as an inefficient use of capital if not managed properly.

Risks

• Potential for significant tax payments under the Amended and Restated Tax Receivable Agreement, which requires ProKidney Delaware to pay 85% of certain tax savings to holders of ProKidney Holdings common units.
• Risk of ProKidney Delaware receiving tax distributions significantly in excess of its tax liabilities and obligations to make payments under the tax receivable agreement, due to differences in allocable income, corporate vs. individual tax rates, and the use of an assumed tax rate.

Future Outlook

The document is primarily a report on completed administrative and corporate restructuring events. It does not provide forward-looking statements or guidance regarding future financial performance, operational plans, or strategic objectives beyond the immediate effects of the domestication.

Industry Context

Corporate domestication and restructuring are common practices for companies, especially those initially incorporated in offshore jurisdictions, as they mature and seek to align with the regulatory and legal frameworks of their primary operating or listing markets, such as the United States. This move can enhance transparency, simplify legal structures, and potentially improve investor confidence by operating under a well-understood legal system like Delaware's.

Comparison to Industry Standards

• This domestication and restructuring aligns with standard corporate governance practices for companies seeking to simplify their legal structure and operate under a U.S. jurisdiction.
• Many companies, particularly those that went public via SPACs or were initially incorporated offshore, undertake similar reorganizations to align with U.S. corporate law, such as the Delaware General Corporation Law (DGCL).
• Specific comparable companies or projects are not detailed in the document, but the process itself is a common corporate finance and legal maneuver.

Corporate Governance

Related Party Transactions

• The Amended and Restated Tax Receivable Agreement involves payments from ProKidney Delaware to holders of common units of ProKidney Holdings, which could include former limited partners of PKLP and potentially related parties.
• The Holdings LLCA provides for tax distributions to ProKidney Holdings members, which would include ProKidney Delaware and other former limited partners of PKLP, some of whom may be related parties.

Stakeholder Impact

• Shareholders: Rights are now governed by Delaware law, which is generally well-understood and provides robust shareholder protections. The conversion of shares and RSRs ensures continuity of ownership interests.
• Employees: Amendments to the Incentive Equity Plan and Employee Stock Purchase Plan ensure continuity of their equity-based compensation and benefits.
• Management/Directors: Indemnification agreements provide enhanced protection for their service.

Next Steps

• Ongoing governance of ProKidney Holdings under the new Holdings LLCA.
• Continued operation under the amended and restated material agreements.
• Compliance with U.S. federal income tax considerations related to the domestication and ownership of common stock.

Key Dates

Keywords

ProKidney Corp, Domestication, Delaware, Cayman Islands, Corporate Restructuring, SEC Filing, 8-K, Tax Receivable Agreement, Lock-Up Agreement, Exchange Agreement, Corporate Governance, Nasdaq, PROK, Subsidiary Restructuring, Limited Liability Company Agreement